Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nacho Aguilo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 9, 2018
Vaccination against tuberculosisCarlos Martin, Nacho Aguilo, Jesús Gonzalo-Asensio
Journal of Visualized Experiments : Jove|September 30, 2016
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in MiceSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Microbiology Spectrum|July 16, 2017
Breaking Transmission with Vaccines: The Case of TuberculosisJesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova, et al.
Frontiers in Immunology|January 13, 2018
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB EpidemicJesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|April 28, 2017
MTBVAC from discovery to clinical trials in tuberculosis-endemic countriesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Expert Review of Vaccines|November 8, 2013
Recent developments in tuberculosis vaccinesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Plos One|April 8, 2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn miceNacho Aguilo, Santiago Uranga, Dessislava Marinova, et al.
The Journal of Infectious Diseases|October 24, 2015
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent MechanismNacho Aguilo, Samuel Alvarez-Arguedas, Santiago Uranga, et al.
ALTEX|May 21, 2014
A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicityMarilena P Etna, Elena Giacomini, Martina Severa, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|April 9, 2018
Vaccination against tuberculosisCarlos Martin, Nacho Aguilo, Jesús Gonzalo-Asensio
Journal of Visualized Experiments : Jove|September 30, 2016
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in MiceSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Microbiology Spectrum|July 16, 2017
Breaking Transmission with Vaccines: The Case of TuberculosisJesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova, et al.
Frontiers in Immunology|January 13, 2018
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB EpidemicJesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|April 28, 2017
MTBVAC from discovery to clinical trials in tuberculosis-endemic countriesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Expert Review of Vaccines|November 8, 2013
Recent developments in tuberculosis vaccinesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Plos One|April 8, 2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Tuberculosis (Edinburgh, Scotland)|January 21, 2016
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn miceNacho Aguilo, Santiago Uranga, Dessislava Marinova, et al.
The Journal of Infectious Diseases|October 24, 2015
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent MechanismNacho Aguilo, Samuel Alvarez-Arguedas, Santiago Uranga, et al.
ALTEX|May 21, 2014
A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicityMarilena P Etna, Elena Giacomini, Martina Severa, et al.
Pageof 4